Showing results (51-60 of 90) with videos related to
Sort By:
Pageof 9
Annual Review of Pharmacology and Toxicology|July 25, 2019
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics DataJill M Pulley, Jillian P Rhoads, Rebecca N Jerome, et al.Journal of Clinical Epidemiology|December 3, 2015
A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing programJonathan S Schildcrout, Yaping Shi, Ioana Danciu, et al.Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Study protocol and statistical analysis plan for a randomized controlled trial evaluating the safety and feasibility of the recombinant human platelet-derived growth factor B (rhPDGF-BB)-enhanced collagen plug for complex perianal fistula healingMarissa C Kuo, Samuel A Younan, Melissa D Lempicki, et al.The Pharmacogenomics Journal|August 12, 2015
Attitudes of clinicians following large-scale pharmacogenomics implementationJ F Peterson, J R Field, Y Shi, et al.Journal of Biomedical Informatics|February 12, 2011
StarBRITE: the Vanderbilt University Biomedical Research Integration, Translation and Education portalPaul A Harris, Jonathan A Swafford, Terri L Edwards, et al.Journal of the American College of Cardiology|May 4, 2019
Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and ProteomicsQuinn S Wells, Deepak K Gupta, J Gustav Smith, et al.American Journal of Human Genetics|April 6, 2010
Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical recordMarylyn D Ritchie, Joshua C Denny, Dana C Crawford, et al.Targeted Oncology|December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) ProgramJill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.Molecular Cancer Therapeutics|October 9, 2020
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A Werfel, Donna J Hicks, Bushra Rahman, et al.Clinical Pharmacology and Therapeutics|December 24, 2015
Physician response to implementation of genotype-tailored antiplatelet therapyJ F Peterson, J R Field, K M Unertl, et al.Pageof 9